16:48 EST NightHawk Biosciences files $200M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NHWK:
- NightHawk Biosciences completes manufacturing run for biopharma company
- NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets
- NightHawk announces strategic shift to pure-play biomanufacturing CDMO
- NightHawk Biosciences Provides Q3 2023 Business Update